Skip to content
Government Federal, Medical Health Aged Care

People living with metastatic breast cancer going to Canberra in call to be counted??

Breast Cancer Network Australia (BCNA) 2 mins read

Not many people know that people living with metastatic breast cancer in Australia are not consistently counted on our cancer registries.  

If you are not counted you are not seen, which means you are ‘invisible’ when health service providers and policymakers plan cancer services and support.  

More than 100 people living with metastatic breast cancer – which is treatable, not curable – took this call to be counted to Canberra. 

Breast Cancer Network Australia (BCNA) – Australia's leading voice for people affected by breast cancer – and Parliamentary Friends of Women's Health are holding a panel discussion – Making Metastatic Breast Cancer Count at Parliament House, Canberra, which will be streamed live.  

Peta Murphy MP, who is living with metastatic breast cancer, and Bridget Archer MP will be co-hosting the panel.  

BCNA Director of Policy, Advocacy and Support Services Vicki Durston and BCNA Consumer Representative Lisa Tobin, from Perth, and who has been living with breast cancer for 23 years and metastatic breast cancer for the past 11 years are also on the panel. 

BCNA kicked off this advocacy campaign in October last year with an issues paper Making Metastatic Breast Cancer Count. 

 

What:             Joint Parliamentary Friends of Women's Health Making Breast Cancer Count

                       Panel discussion: Making Metastatic Breast Cancer Count

                       Hosted by Breast Cancer Network Australia (BCNA)

 

Where:           Main Committee Room 

                      Parliament House 

                       Canberra 

 

When:            8am - 9am Thursday 3 August 2023


About us:

Breast Cancer Network Australia (BCNA) is Australia’s leading breast cancer consumer organisation. BCNA provides information and support to those diagnosed and their supporters, opportunities to connect with others going through a similar situation and work to influence a stronger healthcare system to ensure all Australians affected by breast cancer receive the very best care, treatment and support.


Contact details:

Anna Malbon 

Media & Communications Specialist  

0498 999 477  

[email protected] 

Media

More from this category

  • Government Federal, Mental Health
  • 17/12/2025
  • 17:05
Australians for Mental Health

Australians for Mental Health welcomes mental health spend in mid-year budget update

Australians for Mental Health welcomes mental health spend in mid-year budget update Australians for Mental Health has welcomed the federal government’s decision to fund its election commitment of more than $1 billion for mental health care. The Mid-Year Economic and Fiscal Outlook released today confirms the mental health funding boosts, which will expand services and provide a boost to the workforce. The funding includes $500 million spent on a new network for 20 Youth Specialist Care Centres, $267.3 million for 32 new and upgraded Medicare Mental Health Centres, $225.3 million for 58 new, upgraded or expanded Headspace services and $83.9…

  • Medical Health Aged Care
  • 17/12/2025
  • 13:11
GE HealthCare

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases.…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 17/12/2025
  • 12:03
Jane Morgan Management

LTR Pharma surpasses 1,000 SPONTAN® prescriptions under TGA Special Access Scheme

Highlights More than 1,000 SPONTAN® prescriptions issued under the TGA Special Access Scheme Growing prescriber network with continued uptake in complex ED cases, including post-prostate cancer patients Real-world insights informing US commercial strategy ahead of ROXUS® launch in H1 CY2026 LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that more than 1,000 SPONTAN® prescriptions have now been issued in Australia under the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS Category B). SPONTAN is being prescribed for patients with unmet clinical needs, including men who have not achieved adequate benefit from traditional oral PDE5 inhibitor…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.